Chandan K Jha
Overview
Explore the profile of Chandan K Jha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar C, Jha C
Trop Doct
. 2023 Apr;
53(3):396-397.
PMID: 37113077
Fibrocystic disease of breast is characterized by lumpiness and discomfort. Our 48-year-old perimenopausal patient had a painless progressively enlarging non-tender lump in her right breast since 1 year. On physical...
2.
Singh P, Sahoo R, Sinha U, Mahto M, Jha C
Am Surg
. 2023 Mar;
89(12):5570-5576.
PMID: 36866816
Introduction: Clinical hypocalcemia (CH) following total thyroidectomy (TT) is a potentially life-threatening condition if left untreated. This study aimed at evaluating the accuracy of parathyroid hormone (PTH) measured in the...
3.
Anand A, Jha C, Singh P, Sinha U, Ganesh A, Bhadani P
Am Surg
. 2022 Sep;
89(6):2701-2704.
PMID: 36134572
A wide range of clinical presentations for Cushing's syndrome has been described in the literature. Avascular necrosis of femur is a well-recognized complication of excessive glucocorticoid administration, but its occurrence...
4.
Yadav S, Johri G, Jha C, Jaiswal S, Shekhar S, Kumar V, et al.
Indian J Endocrinol Metab
. 2022 Jun;
26(1):4-12.
PMID: 35662758
The main objective of this systematic review and meta-analysis was to review, assess and report on the studies that have evaluated selective alpha blockade (SAB) vs. non-selective alpha blockade (NSAB)...
5.
Mir R, Jha C, Khullar N, Maqbool M, Dabla P, Mathur S, et al.
Endocr Metab Immune Disord Drug Targets
. 2022 Mar;
22(14):1357-1366.
PMID: 35249513
Frailty is a conglomerated elderly disorder that includes multiple abnormalities, like anemia, an increased titer of catabolic hormones, and compromised physiology of most of the body systems. Many studies have...
6.
Mir R, Elfaki I, Jha C, Javid J, Babakr A, Banu S, et al.
Cardiovasc Hematol Disord Drug Targets
. 2021 Dec;
21(4):266-277.
PMID: 34939556
Background: Cardiovascular diseases (CVD) are important causes of death worldwide. Atherosclerosis is a chronic inflammatory disorder. It is the major cause of CVD and is manifested by ischemic heart disease...
7.
Rathod V, Jha C, Sinha U, Singh P, Kumar A, Bhadani P, et al.
Indian J Surg Oncol
. 2021 Oct;
12(3):598-602.
PMID: 34658590
Only a few countries of the world have a population more than Bihar, but due to the lack of a cancer registry, authentic research, and publications, data regarding the clinicopathological...
8.
Kumar T, Nigam J, Tewari P, Jha C
Cureus
. 2021 Feb;
12(12):e12350.
PMID: 33520545
Papillary thyroid carcinoma (PTC) is one of the most common thyroid malignancy with various histologic variants. Acknowledging the correct histological variant of PTC helps to know about the tumor's nature...
9.
Jha C, Mir R, Elfaki I, Javid J, Babakr A, Banu S, et al.
J Pers Med
. 2020 Oct;
10(4).
PMID: 33114503
Coronary artery disease (CAD) is a major cause of death all over the world. CAD is caused by atherosclerosis which is induced by the interaction of genetic factors and environmental...
10.
Jha C, Mir R, Banu S, Elfaki I, Chahal S
Endocr Metab Immune Disord Drug Targets
. 2019 Oct;
20(3):388-399.
PMID: 31613733
Objective: Coronary artery disease (CAD) is one of the most common causes of death worldwide. Risk factors of CAD include high LDL-C, low high-density lipoprotein (HDL), hypertension, lack of exercise,...